Lawrence Livermore National Laboratory (LLNL) researchers have 3D printed live cells that convert glucose to ethanol and carbon dioxide gas (CO2), a substance that resembles beer, demonstrating a technology that can lead to high biocatalytic efficiency.
Bioprinting living mammalian cells into complex 3D scaffolds has been widely studied and demonstrated for applications ranging from tissue regeneration to drug discovery to clinical implementation. In addition to mammalian cells, there is a growing interest in printing functional microbes as biocatalysts.
Microbes are extensively used in industry to convert carbon sources into valuable end-product chemicals that have applications in the food industry, biofuel production, waste treatment and bioremediation. Using live microbes instead of inorganic catalysts has advantages of mild reaction conditions, self-regeneration, low cost and catalytic speci?city.
The new research, which appears as an ACS Editors’ Choice article in the journal Nano Letters, shows that the additive manufacturing of live whole-cells can assist in research in microbial behaviors, communication, interaction with the microenvironment and for new bioreactors with high volumetric productivity.
In a case study, the team printed freeze-dried live biocatalytic yeast cells (Saccharomyces cerevisiae) into porous 3D structures. The unique engineered geometries allowed the cells to convert glucose to ethanol and CO2 very efficiently and similar to how yeast on its own can be used to make beer. Enabled by this new bio-ink material, the printed structures are self-supporting, with high resolution, tunable cell densities, large scale, high catalytic activity and long-term viability. More importantly, if genetically modified yeast cells are used, high-valuable pharmaceuticals, chemicals, food and biofuels can be produced as well.
“Compared to bulk film counterparts, printed lattices with thin filament and macro-pores allowed us to achieve rapid mass-transfer leading to several-fold increase in ethanol production,” said LLNL materials scientist Fang Qian, the lead and corresponding author on the paper. “Our ink system can be applied to a variety of other catalytic microbes to address broad application needs. The bioprinted 3D geometries developed in this work could serve as a versatile platform for process intensi?cation of an array of bioconversion processes using diverse microbial biocatalysts for production of high-value products or bioremediation applications.”
Other Livermore researchers include Cheng Zhu, Jennifer Knipe, Samantha Ruelas, Joshua Stolaroff, Joshua DeOtte, Eric Duoss, Christopher Spadaccini and Sarah Baker. This work was conducted in collaboration with National Renewable Energy Laboratory.
“There are several benefits to immobilizing biocatalysts, including allowing continuous conversion processes and simplifying product purification,” said chemist Baker, the other corresponding author on the paper. “This technology gives control over cell density, placement and structure in a living material. The ability to tune these properties can be used to improve production rates and yields. Furthermore, materials containing such high cell densities may take on new, unexplored beneficial properties because the cells comprise a large fraction of the materials.”
“This is the first demonstration for 3D printing immobilized live cells to create chemical reactors,” said engineer Duoss, a co-author on the paper. “This approach promises to make ethanol production faster, cheaper, cleaner and more efficient. Now we are extending the concept by exploring other reactions, including combining printed microbes with more traditional chemical reactors to create ‘hybrid’ or ‘tandem’ systems that unlock new possibilities.”
The Latest on: Biocatalysts
via Google News
The Latest on: Biocatalysts
- Industrial Enzymes Is Projected to Reach $8.7 Billion by 2026on November 26, 2021 at 8:54 am
The industrial enzymes market is estimated to be valued at USD 5.9 billion in 2020 and is projected to reach USD 8.7 billion by 2026, recording a CAGR of 6.5%, in terms of value. The growing ...
- Biocatalysts Market Size In 2021 with Top Countries Data : What are the key driving factors for the Biocatalysts Industry? | Latest 100 Pages Reporton November 24, 2021 at 2:00 pm
According to this latest study, in 2021 the growth of Biocatalysts Market will have significant change from previous ...
- Specialty Enzymes Market is Expected to Register a Considerable Growth by 2026on November 24, 2021 at 12:06 am
Stratview Research announces the launch of a new research report on Specialty Enzymes Market by Type Carbohydrases Amylases Cellulases and Other Carbohydrases Proteases Lipases Polymerases Nucleases ...
- How Is The Biotechnology Services Market Benefiting From Collaboration?on November 19, 2021 at 5:40 am
Biocatalysts, Therapeutics), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/epharmacy, Specialty Clinics), COVID-19 Growth And Change Interested to know more about The ...
- Unexpected chemical reaction may offer new industrial applicationson November 9, 2021 at 4:36 am
Biocatalysts or other expensive methods are currently required to activate such reactions. According to the researchers, the new mechanism indicates that cost-effective applications may be ...
- Biocatalysts Market – Comprehensive Study on COVID19 Impact Analysis And Forecast by Top Performing Regions, Product Types And Growth Rate.on October 31, 2021 at 11:45 pm
BiocatalystsA wide ranging Biocatalysts Market survey report is an established and consistent source of information which gives telescopic view of the existing market trends, emerging products, ...
- Engineering of Pd-single-atom coordinated biocatalysts for chem-/sono-/photo-trimodal tumor therapieson October 29, 2021 at 4:18 am
(Nanowerk Spotlight) The diversity, complexity, and heterogeneity of malignant tumor seriously undermine the efficiency of mono-modal treatment. Recently, multi-modal therapeutics with enhanced ...
- Winner: 2021 Chemistry Biology Interface Division Horizon Prize:on June 8, 2021 at 2:50 am
These medicines must also be produced in highly pure form for use in patients. One such approach employs enzymes or biocatalysts which are safe, highly selective and produce minimal waste. The ...
via Bing News